Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Ivenix Appoints New Head With $42m Cash Infusion

This article was originally published in Clinica

Executive Summary

Ivenix, a company developing a next-generation infusion pump system, has appointed Stuart Randle CEO. The appointment comes a few months after the Amesbury, Massachusetts firm bagged a $42m financing round, led by new investor, China-based WuXi Healthcare Ventures. Prior to joining Ivenix, Randle was president and CEO of another Massachusetts firm, GI Dynamics, which was focused on type 2 diabetes and obesity. The infusion system market is not new to Ivenix’s new head: he began his career at Baxter where he spent 10 years in various senior sales and marketing roles.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst